Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00844818 · ClinicalTrials.gov registry record · NA

An Intervention to Address Parental Smoking During the Postpartum Hospitalization.

A NA study of Tobacco Use and Parental Smoking, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
101
Enrollment target
1
Study location

NCT00844818: Completed NA study of Tobacco Use and Parental Smoking, sponsored by Massachusetts General Hospital.

NCT00844818 is a NA study of Tobacco Use and Parental Smoking that has completed, run by Massachusetts General Hospital. The registered enrollment target is 101 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00844818, a NA study of Tobacco Use and Parental Smoking, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to find better ways to help parents quit smoking, thus improving their own health, the health of their children, and the health of other family members. This study tested the feasibility and acceptability of enrolling parents into a telephone quitline during postpartum hospitalization. Half of the parents in the study received quit smoking assistance (intervention group), and half of the parents did not (control group). The percentage of parental smokers who are enrolled in quit smoking programs by the study follow-up will be greater in the intervention group than in the control group.

Interventions

  • BEHAVIORAL Telephone Quitline Enrollment

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2005-02
Est. Completion 2006-04
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT00844818 record still lists

NCT00844818 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (73% lower).

The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 1 intervention - of which Telephone Quitline Enrollment is the first listed.

NCT00844818 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00844818 about?

NCT00844818 is a clinical study titled "An Intervention to Address Parental Smoking During the Postpartum Hospitalization.". The purpose of the study is to find better ways to help parents quit smoking, thus improving their own health, the health of their children, and the health of other family members. This study tested the feasibility and acceptability of enrolling parents into a telephone quitline during postpartum ho...

What is the current status of trial NCT00844818?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2005-02. Estimated completion is 2006-04.

What conditions does trial NCT00844818 study?

This clinical trial studies the following conditions: Tobacco Use, Parental Smoking.

What interventions are being tested in trial NCT00844818?

The interventions under investigation include: Telephone Quitline Enrollment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00844818?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00844818 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00844818's enrollment target sits among peer trials

101 38th of 76 higher than 39 of 76 other Tobacco Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00844818, the US trial registry maintained by the National Library of Medicine. NCT00844818 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.